Clinical trial
Vortioxetine in the Treatment of Depression and Concomitant Migraine: an Explorative Study
NCT07579481 is registered in ClinicalTrials.gov with Fondazione Policlinico Universitario Agostino Gemelli IRCCS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Vortioxetine in the Treatment of Depression and Concomitant Migraine: an Explorative Study
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 28, 2025
- Completion date
- September 30, 2026
- Enrollment
- 31 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
depression, migraine